Shift from Eradication to Control: An Adaptive Therapy Approach

This theoretical review explores the paradigm shift in oncology from maximum tolerated dose (MTD) eradication strategies to evolutionary-based adaptive therapy. By leveraging intratumoral competition between drug-sensitive and drug-resistant cell populations, adaptive therapy aims to maintain a stable tumor burden, delay treatment resistance, and improve long-term clinical outcomes.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-17
DOI
https://doi.org/10.5281/zenodo.24321896
Primary Topic
Mathematical Biology Tumor Growth
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Shift from Eradication to Control: An Adaptive Therapy Approach

Rahma Al-zuhairi
2 links
Zenodo (CERN European Organization for Nuclear Research)
Mathematical Biology Tumor Growth
preprint

Shift from Eradication to Control: An Adaptive Therapy Approach

Rahma Al-zuhairi
preprint en

Abstract

This theoretical review explores the paradigm shift in oncology from maximum tolerated dose (MTD) eradication strategies to evolutionary-based adaptive therapy. By leveraging intratumoral competition between drug-sensitive and drug-resistant cell populations, adaptive therapy aims to maintain a stable tumor burden, delay treatment resistance, and improve long-term clinical outcomes.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Mathematical Biology Tumor Growth
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon